Sharing is Caring!
The Canadian province of Alberta reported its first death of a patient from a rare blood clot condition after receiving the AstraZeneca (AZN.L) COVID-19 vaccine, its chief medical officer said.
Canada has reported at least five cases of blood clots following immunization with the vaccine, but public health officials maintain the benefits of the AstraZeneca shot outweigh the potential risks.
The Alberta case, of a woman in her 50s, marks the second case of blood clots, and the only death after more than 253,000 doses of AstraZeneca were administered in the province, Alberta’s chief medical officer of health Dr. Deena Hinshaw said in a statementon Tuesday.
602 views